Schambach A, Bohne J, Baum C, Hermann F G, Egerer L, von Laer D, Giroglou T
Department of Hematology, Hemostaseology and Oncology, Hannover Medical School, Hannover, Germany.
Gene Ther. 2006 Apr;13(7):641-5. doi: 10.1038/sj.gt.3302698.
Introduction of the post-transcriptional regulatory element (PRE) of woodchuck hepatitis virus (WHV) into the 3' untranslated region of retroviral and lentiviral gene transfer vectors enhances both titer and transgene expression. Optimal use of the PRE is often necessary to obtain vectors with sufficient performance for therapeutic applications. The enhancing activity of the PRE depends on the precise configuration of its sequence and the context of the vector and cell into which it is introduced. However, data obtained in the context of WHV-associated hepatocellular carcinomas suggests that the PRE might potentially contribute to tumorigenesis, especially if encoding a truncated version of the WHV X protein. Oncogenic side effects of lentiviral vectors containing the PRE have reinforced these safety concerns, although a causal role of the PRE remained unproven. Here, we demonstrate that PRE mutants can be generated that are devoid of X protein open reading frames (ORFs) as well as other ORFs exceeding 25 amino acids, without significant loss of RNA enhancement activity. Furthermore, the X protein promoter could be deleted without compromising the enhancement of vector titers and transgene expression. Such a modified PRE sequence appears useful for future vector design.
将土拨鼠肝炎病毒(WHV)的转录后调控元件(PRE)引入逆转录病毒和慢病毒基因转移载体的3'非翻译区,可提高病毒滴度和转基因表达。为了获得具有足够性能用于治疗应用的载体,通常需要最佳地使用PRE。PRE的增强活性取决于其序列的精确构型以及引入它的载体和细胞的背景。然而,在与WHV相关的肝细胞癌背景下获得的数据表明,PRE可能潜在地促进肿瘤发生,特别是如果编码WHV X蛋白的截短版本。含有PRE的慢病毒载体的致癌副作用加剧了这些安全担忧,尽管PRE的因果作用仍未得到证实。在这里,我们证明可以产生不含X蛋白开放阅读框(ORF)以及超过25个氨基酸的其他ORF的PRE突变体,而不会显著丧失RNA增强活性。此外,可以删除X蛋白启动子而不影响载体滴度和转基因表达的增强。这种修饰的PRE序列似乎对未来的载体设计有用。